ArticleFrontiers in endocrinology2021

Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.

Rosario Pivonello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.